Dr. Ebetino is a consultant for several start-up biotech organisations, and has continuing research efforts with several academic collaborators. He has recently been leading the Drug Discovery Department and the Medicinal Chemistry research laboratories which he established for Warner Chilcott in Ireland. Experience includes over 27 years of Pharmaceutical R&D, with research and publications spanning a variety of therapeutic areas including bone metabolism, arthritis, obesity, anti-infectives, Gl Disease, and cancer. Hal is most well-known for many years of research on the bisphosphonate class of bone active agents, and was part of the Procter & Gamble team that discovered and developed the therapeutic agent Actonel® for osteoporosis. He also has roles as a Visiting Scholar at the University of Southern California, Los Angeles, Visiting Professor at Queen’s University, Belfast and as an Academic Visitor at the University of Oxford, UK. He has also led many co-operative research efforts with academic partners for over 25 years.